REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 439 filers reported holding REPLIGEN CORP in Q1 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,859 | +26.7% | 62 | +12.7% | 0.00% | – |
Q2 2023 | $7,780 | -16.0% | 55 | 0.0% | 0.00% | – |
Q1 2023 | $9,260 | -0.6% | 55 | 0.0% | 0.00% | – |
Q4 2022 | $9,312 | -6.9% | 55 | 0.0% | 0.00% | – |
Q3 2022 | $10,000 | -9.1% | 55 | -16.7% | 0.00% | – |
Q2 2022 | $11,000 | -93.9% | 66 | -93.1% | 0.00% | -100.0% |
Q1 2022 | $179,000 | +1093.3% | 951 | +1629.1% | 0.00% | – |
Q4 2021 | $15,000 | -6.2% | 55 | 0.0% | 0.00% | – |
Q3 2021 | $16,000 | +45.5% | 55 | 0.0% | 0.00% | – |
Q2 2021 | $11,000 | -100.0% | 55 | -93.4% | 0.00% | -100.0% |
Q1 2021 | $160,972,000 | +699778.3% | 828 | +595.8% | 0.00% | – |
Q4 2020 | $23,000 | +4.5% | 119 | -20.7% | 0.00% | -100.0% |
Q3 2020 | $22,000 | -12.0% | 150 | -25.0% | 0.00% | 0.0% |
Q2 2020 | $25,000 | +92.3% | 200 | +48.1% | 0.00% | – |
Q1 2020 | $13,000 | +44.4% | 135 | +35.0% | 0.00% | – |
Q4 2019 | $9,000 | +28.6% | 100 | 0.0% | 0.00% | – |
Q3 2019 | $7,000 | -12.5% | 100 | 0.0% | 0.00% | – |
Q2 2019 | $8,000 | +33.3% | 100 | 0.0% | 0.00% | – |
Q3 2018 | $6,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
Miura Global Management | 85,000 | $24,564,000 | 3.81% |
Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |